Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Standalone and Consolidated ....
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has informed the stock exchanges that its Board of Directors will meet on Friday, November 14, 2025, in New Delhi. The main agenda is to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and half year ended September 30, 2025 (i.e., Q2 FY26 and H1 FY26). The filing is made under SEBI LODR Regulation 29, which requires listed companies to give advance notice of board meetings that consider financial results. The trading window for designated persons remains closed until November 16, 2025, in line with insider trading rules.
No direct impact on shareholders or stock price at this stage — this is a routine advance intimation. Investors should watch for the actual Q2/H1 FY26 results on November 14, 2025 for revenue, profit, and margin trends.